Fr
Frontline BioSciences
Suzhou CNFounded 201980 employees
Private CapbiotechPrivateOncology
Platform: Molecular Glue
Market Cap
N/A
All Drugs
4
Clinical Trials
9
Failed / Terminated
4
FDA Approved
1
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| FRO-9633 | FRO-9633 | Phase 3 | 2 | SGLT2 | FTDGastric Ca | ||
| Lisozasiran | FRO-7520 | NDA/BLA | 1 | B7-H3 | NMOSD | ||
| Talacagene | FRO-2616 | Phase 2/3 | 2 | AuroraA | Breast CaNMOSD | ||
| FRO-509 | FRO-509 | Approved | 4 | KIF18A | FLCKD |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (7)